FeesSafety
Pluang+

NEAR price drops below $5 despite $5.42M ETF inflows over three weeks

Market News
20 Oct 2026, 16:23 WIB
Crypto Economy
View Source
Bullish
NEAR price drops below $5 despite $5.42M ETF inflows over three weeks

NEAR's market price slipped from $5 to $4.70 even as Bitwise's NRR ETF recorded $5.42 million in net inflows. This marks the third consecutive week of positive ETF inflows, totaling over $80 million, indicating strong institutional interest despite the price dip. The continued inflows suggest investor confidence in NEAR's long-term potential, though short-term price volatility remains.

BlackRock's proposal of a buffered Bitcoin ETF comes as a backdrop to ongoing market movements. For readers following cryptocurrency markets, here is Pluang's snapshot as of Oct 20, 2026 19:51 WIB: Among 50 major cryptocurrencies priced on Pluang, 20 rose and 29 fell today. Notable movers include XNO (Nano) at Rp6.213 with a 1-day change of +5.93% and balanced Pluang order activity, SAND (The Sandbox) at Rp1.016 down 4.98% with more buy orders, and CRV (Curve DAO Token) at Rp6.609 up 4.34% but with predominantly sell orders. Typical hold times range from 62 to 123 days across these assets.

More News

Nvidia posts triple-digit revenue growth but stock struggles amid leadership and regulatory concerns.

Nvidia posts triple-digit revenue growth but stock struggles amid leadership and regulatory concerns.

Nvidia reported exceptional third-quarter earnings with revenue and profits more than doubling year-over-year, driven by strong demand for its AI infrastructure. However, the stock price remains subdued due to uncertainty following founder Jensen Hua...

Company Fundamentals
Neutral
52 minutes ago
Phathom reports $84.7M Q3 revenue, $0 copay for VOQUEZNA, and reaffirms 2026 revenue guidance.

Phathom reports $84.7M Q3 revenue, $0 copay for VOQUEZNA, and reaffirms 2026 revenue guidance.

Phathom Pharmaceuticals reported third-quarter net revenues of $84.7 million, driven by strong sales of VOQUEZNA, its treatment for GERD. The company introduced a $0 copay program through BlinkRx for commercially insured patients to boost access and ...

Company Fundamentals
Bullish
54 minutes ago
Target boosts store traffic 5.6% and food sales nearly 7% in Q3 2026 with tech-driven inventory upgrades.

Target boosts store traffic 5.6% and food sales nearly 7% in Q3 2026 with tech-driven inventory upgrades.

In Q3 2026, Target reported a 5.6% increase in comparable store sales and nearly 7% growth in food and beverage sales, driven by stronger customer visits and expanded automated inventory replenishment covering over 90% of products. Management is simp...

Company Fundamentals
Bullish
58 minutes ago
KBR's Q3 revenue rises 5% with record $5.8B tech backlog; plans Trinzic spin-off on Jan 4, 2027

KBR's Q3 revenue rises 5% with record $5.8B tech backlog; plans Trinzic spin-off on Jan 4, 2027

KBR reported a 5% revenue increase in Q3 2026 to $2.03 billion, driven by growth in its commercial technology business. The company's sustainable tech backlog hit a record $5.8 billion, up over 50% year-over-year, providing strong revenue visibility....

Company Fundamentals
Bullish
1 hour ago
John B. Sanfilippo sees contract manufacturing growth offset retail losses amid industry shifts

John B. Sanfilippo sees contract manufacturing growth offset retail losses amid industry shifts

John B. Sanfilippo reported a 41.3% increase in contract manufacturing volume, offsetting declines in private brand retail sales due to changes in sourcing by key partners. The company is investing in high-speed production lines to expand private lab...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App